Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Adamax vs P21
An educational, source-based comparison of Adamax and P21 — how each peptide works, what it's researched for, and what to know before going deeper.
A modified form of Semax with additional N-terminal adamantyl group. Research suggests enhanced stability and penetration across the blood-brain barrier, with amplified neurotrophic and neuroprotective effects compared to parent compound.
- Neuroprotection in acute ischemia
- Cognitive enhancement in healthy adults
- Recovery from traumatic brain injury
- • Russian-origin research; limited Western clinical data.
- • Not FDA-approved.
A synthetic peptide derived from cerebrolysin. Research suggests it promotes synaptic plasticity by enhancing BDNF expression and inhibiting prolyl endopeptidase, an enzyme involved in neurodegenerative processes.
- Synaptic plasticity and memory
- Neuroprotection in Alzheimer's models
- Cognitive recovery after brain injury
- • Experimental; limited human data available.
- • Not FDA-approved.
Adamax vs P21 — Key differences
- Class: Adamax is classified as Nootropic · Neuroprotection, while P21 is Nootropic · Neuroprotection.
- Primary research focus: Adamax — neuroprotection in acute ischemia; P21 — synaptic plasticity and memory.
- Tag: Cognition vs Cognition · Neuroprotection.